FAQ
Discover answers to common questions about the Microbiome Summer School in our comprehensive FAQ section
GUT Microbiome Summer School
The microbiome refers to the diverse community of microorganisms that inhabit various environments, such as the human body, soil, water, and air. In the context of human health, the microbiome within the gastrointestinal tract plays a crucial role in digestion, immune system regulation, and even mental health. These microorganisms, including bacteria, fungi, viruses, and archaea, contribute to nutrient metabolism, synthesis of vitamins, and protection against pathogens.
In healthy conditions, the gut microbiota exhibits stability, resilience, and symbiotic interaction with the host. A healthy microbiota community often demonstrates high taxonomic diversity, high microbial gene richness and stable core microbiota. It should be noted that the relative distribution of microorganisms is unique between individuals and may undergo variations within the same individual.
GM doesn't operate in isolation but rather engages in dynamic interactions with other bodily systems, including the brain (via the gut-brain axis), the respiratory system (via the gut-lung axis), and liver functions (via the gut-liver axis). Imbalances in the microbiome have been linked to various health issues, including inflammatory bowel diseases, allergies, and metabolic disorders. Understanding and maintaining a healthy microbiome is essential for overall well-being and disease prevention.
Alterations in GM composition and function, whether through natural shifts or interventions like Faecal Microbiota Transplantation (FMT), probiotics/antibiotics administration can have profound implications for human health. FMT, in particular, has emerged as a potent therapeutic tool, demonstrating its efficacy in treating a wide array of disease.
In the last decade, modulation of the gut microbiota has gained increasing evidence as a route for improving a range of clinical outcomes for patients. Initially, FMT was shown to successfully treat C. difficile infections with a much greater success rate than the standard of care i.e., antibiotics. Subsequently FMT, has been approved by NICE for recurrent C. difficile infections and there are currently >400 clinical trials, globally, where FMT is being used in a wide range of clinical settings to treat a wide range of illnesses or improve drug response, including during chemotherapy and immunotherapy in cancer.
From combating C. difficile infections to augmenting patients' responses to chemotherapy and immunotherapy in cancer treatment, the clinical applications of FMT are vast and increasingly recognized. Its ability to restore balance to the gut microbiome and unleash therapeutic benefits underscores its significance as a promising tool for improving patient outcomes across diverse medical conditions.
FAQ
Frequently Asked Questions
Find answers to your questions about the program, application process, and more in our comprehensive FAQ section
Applicants must demonstrate good knowledge of English, and have a background in medical studies – preferably at an advanced level or postgraduate level. This includes scientists in the relevant fields of science (biologists, chemists, pharmacologists and biologists), clinicians and clinical researchers.
Selection is based on the evaluation and scoring of the applicant's CV, with a focus on academic achievements.
Yes, a dedicated platform for all updates and announcements will be available.
No, scholarships are not offered for this program.
Applications are open until the 23rd of August.
Secure your spot as there is a limited number of participants (40 total)
Ready to Advance Your Expertise?
Take the Next Step: Secure Your Spot Today
